These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


126 related items for PubMed ID: 3091244

  • 1. A syndrome of microangiopathic hemolytic anemia, renal impairment, and pulmonary edema in chemotherapy-treated patients with adenocarcinoma.
    Sheldon R, Slaughter D.
    Cancer; 1986 Oct 01; 58(7):1428-36. PubMed ID: 3091244
    [Abstract] [Full Text] [Related]

  • 2. Carcinoma-associated hemolytic-uremic syndrome: a complication of mitomycin C chemotherapy.
    Cantrell JE, Phillips TM, Schein PS.
    J Clin Oncol; 1985 May 01; 3(5):723-34. PubMed ID: 3923162
    [Abstract] [Full Text] [Related]

  • 3. Mitomycin C associated hemolytic uremic syndrome.
    Jain S, Seymour AE.
    Pathology; 1987 Jan 01; 19(1):58-61. PubMed ID: 3108839
    [Abstract] [Full Text] [Related]

  • 4. Microangiopathic hemolytic anemia, noncardiac pulmonary edema, and renal failure after treatment of metastatic adenocarcinoma of the colon with 5-fluorouracil and mitomycin-C: report of a case.
    Claycomb CL, Berkovic M.
    J Am Osteopath Assoc; 1986 Aug 01; 86(8):499-503. PubMed ID: 3093413
    [No Abstract] [Full Text] [Related]

  • 5. Mitomycin-induced hemolytic-uremic syndrome. Successful treatment with corticosteroids and intense plasma exchange.
    Lyman NW, Michaelson R, Viscuso RL, Winn R, Mulgaonakar S, Jacobs MG.
    Arch Intern Med; 1983 Aug 01; 143(8):1617-8. PubMed ID: 6870446
    [Abstract] [Full Text] [Related]

  • 6. Microangiopathic hemolytic anemia, renal failure, and noncardiogenic pulmonary edema: a chemotherapy-induced syndrome.
    Jolivet J, Giroux L, Laurin S, Gruber J, Bettez P, Band PR.
    Cancer Treat Rep; 1983 May 01; 67(5):429-34. PubMed ID: 6406059
    [Abstract] [Full Text] [Related]

  • 7. [Hemolytic-uremic syndrome caused by mitomycin C].
    de Insausti CL, Gutiérrez LE.
    Sangre (Barc); 1988 Aug 01; 33(4):319-20. PubMed ID: 3142062
    [No Abstract] [Full Text] [Related]

  • 8. Mitomycin-induced hemolytic-uremic syndrome.
    Proia AD, Harden EA, Silberman HR.
    Arch Pathol Lab Med; 1984 Dec 01; 108(12):959-62. PubMed ID: 6210069
    [Abstract] [Full Text] [Related]

  • 9. Pulmonary veno-occlusive disease associated with microangiopathic hemolytic anemia and chemotherapy of gastric adenocarcinoma.
    Waldhorn RE, Tsou E, Smith FP, Kerwin DM.
    Med Pediatr Oncol; 1984 Dec 01; 12(6):394-6. PubMed ID: 6548790
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Hemolytic-uremic syndrome associated with mitomycin therapy.
    Pavy MD, Wiley EL, Abeloff MD.
    Cancer Treat Rep; 1982 Mar 01; 66(3):457-61. PubMed ID: 7060035
    [No Abstract] [Full Text] [Related]

  • 19. [Chemotherapy-associated hemolytic uremic syndrome--a case report].
    Kikuchi H, Kanamaru R.
    Gan To Kagaku Ryoho; 1992 Sep 01; 19(11):1927-9. PubMed ID: 1519930
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 7.